The ROE as of November 2025 (TTM) for Eucrates Biomedical Acquisition Corp. (EUCR) is 10.27%

According to Eucrates Biomedical Acquisition Corp.’s latest financial reports and current stock price. The company's current ROE is 10.27%. This represents a change of 265.00% compared to the average of 2.81% of the last 4 quarters.

Eucrates Biomedical Acquisition Corp. (EUCR) Historical ROE (quarterly & annually)

How has EUCR ROE performed in the past?

The mean historical ROE of Eucrates Biomedical Acquisition Corp. over the last ten years is 22.91%. The current 10.27% ROE has changed -55.18% with respect to the historical average. Over the past ten years (40 quarters), EUCR's ROE was at its highest in in the December 2022 quarter at 6.40%. The ROE was at its lowest in in the December 2021 quarter at -52.68%.

Eucrates Biomedical Acquisition Corp. (EUCR) ROE by Quarter and Year

Discovering the peaks and valleys of Eucrates Biomedical Acquisition Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Eucrates Biomedical Acquisition Corp. (EUCR) Average ROE

How has EUCR ROE performed in the past?

The current ROE of Eucrates Biomedical Acquisition Corp. (EUCR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Eucrates Biomedical Acquisition Corp. (EUCR) ROE vs. Peers

How is EUCR’s ROE compared to its peers?

Eucrates Biomedical Acquisition Corp.’s ROE is less than Forum Merger IV Corporation (0%), less than Finnovate Acquisition Corp. (2.37%), greater than Pono Capital Two, Inc. (-22.32%), less than Broad Capital Acquisition Corp. (18.96%), greater than The Growth for Good Acquisition Corporation (-12.74%), less than Mountain Crest Acquisition Corp. IV (2.34%), greater than Prime Number Acquisition I Corp. (-0.26%), greater than Artemis Strategic Investment Corporation (-13.43%), less than Forbion European Acquisition Corp. (1.79%), less than UTA Acquisition Corporation (0%), less than BYTE Acquisition Corp. (0%), less than Worldwide Webb Acquisition Corp. (182.98%), less than TKB Critical Technologies 1 (1.03%), less than OPY Acquisition Corp. I (94.46%), greater than Target Global Acquisition I Corp. (0.03%), greater than null (-26.22%),

Build a custom stock screener for Eucrates Biomedical Acquisition Corp. (EUCR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eucrates Biomedical Acquisition Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eucrates Biomedical Acquisition Corp. (EUCR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eucrates Biomedical Acquisition Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.